Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) EBT (2016 - 2025)

Axogen has reported EBT over the past 16 years, most recently at -$11.1 million for Q4 2025.

  • Quarterly results put EBT at -$11.1 million for Q4 2025, down 2158.78% from a year ago — trailing twelve months through Dec 2025 was -$14.4 million (down 38.95% YoY), and the annual figure for FY2025 was -$14.4 million, down 38.94%.
  • EBT for Q4 2025 was -$11.1 million at Axogen, down from $474000.0 in the prior quarter.
  • Over the last five years, EBT for AXGN hit a ceiling of $541000.0 in Q4 2024 and a floor of -$11.7 million in Q1 2022.
  • Median EBT over the past 5 years was -$5.2 million (2021), compared with a mean of -$5.2 million.
  • Peak annual rise in EBT hit 124.78% in 2025, while the deepest fall reached 2158.78% in 2025.
  • Axogen's EBT stood at -$5.3 million in 2021, then increased by 1.86% to -$5.2 million in 2022, then increased by 9.09% to -$4.7 million in 2023, then surged by 111.51% to $541000.0 in 2024, then crashed by 2158.78% to -$11.1 million in 2025.
  • The last three reported values for EBT were -$11.1 million (Q4 2025), $474000.0 (Q3 2025), and -$80000.0 (Q2 2025) per Business Quant data.